Effects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro

Huang X, Wong MK, Yi H, et al: Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein. Cancer Res. 62:5727–5735. 2002.PubMed/NCBI

Duo J, Ying GG, Wang GW and Zhang L: Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via Bcl-2 and Bax regulation. Mol Med Rep. 5:1453–1456. 2012.PubMed/NCBI

Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar

Mallin K, Palis BE, Watroba N, et al: Completeness of American Cancer Registry Treatment Data: implications for quality of care research. J Am Coll Surg. 216:428–437. 2013. View Article : Google Scholar : PubMed/NCBI

Slusarz A, Shenouda NS, Sakla MS, et al: Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res. 70:3382–3390. 2010. View Article : Google Scholar : PubMed/NCBI

Cheng S, Gao N, Zhang Z, et al: Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of Bax. Clin Cancer Res. 16:5679–5691. 2010. View Article : Google Scholar : PubMed/NCBI

Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L and Pintzas A: Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther. 6:2591–2599. 2007. View Article : Google Scholar : PubMed/NCBI

Qin Y, He LY, Chen Y, Wang WY, Zhao XH and Wu MY: Quercetin affects leptin and its receptor in human gastric cancer MGC-803 cells and JAK-STAT pathway. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 28:12–16. 2012.(In Chinese).

Neibert KD and Maysinger D: Mechanisms of cellular adaptation to quantum dots - the role of glutathione and transcription factor EB. Nanotoxicology. 6:249–262. 2012. View Article : Google Scholar : PubMed/NCBI

Chen SS, Corteling R, Stevanato L and Sinden J: Polyphenols inhibit indoleamine 3,5-dioxygenase-1 enzymatic activity - a role of immunomodulation in chemoprevention. Discov Med. 14:327–333. 2012.PubMed/NCBI

Heinritz W, Paasch U, Sticherling M, et al: Evidence for a founder effect of the germline fumarate hydratase gene mutation R58P causing hereditary leiomyomatosis and renal cell cancer (HLRCC). Ann Hum Genet. 72(Pt 1): 35–40. 2008.PubMed/NCBI

Comalada M, Camuesco D, Sierra S, et al: In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol. 35:584–592. 2005. View Article : Google Scholar

Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH and Huynh H: The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 25:647–659. 2004. View Article : Google Scholar : PubMed/NCBI

Kuo PC, Liu HF and Chao JI: Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells. J Biol Chem. 279:55875–55885. 2004. View Article : Google Scholar : PubMed/NCBI

Kim WK, Bang MH, Kim ES, et al: Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. J Nutr Biochem. 16:155–162. 2005. View Article : Google Scholar : PubMed/NCBI

Li F and Altieri DC: The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res. 59:3143–3151. 1999.

Yoshida M, Yamamoto M and Nikaido T: Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res. 52:6676–6681. 1992.PubMed/NCBI

Ryan BM, O’Donovan N and Duffy MJ: Survivin: a new target for anti-cancer therapy. Cancer Treat Rev. 35:553–562. 2009. View Article : Google Scholar : PubMed/NCBI